Identification of a novel fusion gene, TRIM52-RACK1, in oral squamous cell carcinoma

Tao Pan1, Yong-Guo Li2, Ke-Yi Li2

  • 1Key Lab of Precision Biomedicine & Department of Stomatology, Liaocheng People's Hospital, College of Stomatology, Shandong First Medical University, China.

Insights

Researchers identified 11 novel gene fusions in oral squamous cell carcinoma (OSCC). The TRIM52-RACK1 fusion promotes OSCC progression, suggesting it as a potential therapeutic target for this cancer.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Gene fusions are increasingly recognized in cancer development and progression.
  • Novel fusion genes are potential therapeutic targets.
  • The role of gene fusions in oral squamous cell carcinoma (OSCC) progression is understudied.

Purpose of the Study:

  • To identify novel gene fusions in oral squamous cell carcinoma (OSCC) cells.
  • To investigate the functional role of the TRIM52-RACK1 fusion gene in OSCC progression.
  • To evaluate TRIM52-RACK1 as a potential therapeutic target for OSCC.

Main Methods:

  • Identification of gene fusions in OSCC cells using molecular techniques.
  • Analysis of the genomic structure of the TRIM52-RACK1 fusion.
  • In vitro functional assays to assess the impact of TRIM52-RACK1 on OSCC cell proliferation, migration, and invasion.

Main Results:

  • Eleven fused genes were identified in OSCC cells.
  • The TRIM52-RACK1 fusion gene results from a deletion at chromosomal location 5q35.3.
  • TRIM52-RACK1 significantly promoted OSCC cell proliferation, migration, and invasion in vitro.

Conclusions:

  • TRIM52-RACK1 is a novel oncogenic fusion gene in oral squamous cell carcinoma (OSCC).
  • TRIM52-RACK1 plays a crucial role in promoting OSCC progression.
  • TRIM52-RACK1 represents a promising therapeutic target for OSCC treatment.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K